Clinical Trial Update: A Study of Famitinib in Patients With Advanced Metastatic Renal Cell Cancer [Phase 2]

View source ↗

Summary

Phase 2 study of famitinib in advanced/metastatic renal cell carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Famitinib (Famitinib)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Renal Cell Cancer, Metastatic Renal Cell Cancer | Phase 2 | Status: COMPLETED